nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C8—Mometasone—systemic scleroderma	0.178	0.243	CbGbCtD
Loratadine—ABCB1—Lisinopril—systemic scleroderma	0.0813	0.111	CbGbCtD
Loratadine—CYP2C9—Leflunomide—systemic scleroderma	0.0799	0.109	CbGbCtD
Loratadine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0708	0.0966	CbGbCtD
Loratadine—ABCB1—Captopril—systemic scleroderma	0.0608	0.0831	CbGbCtD
Loratadine—CYP2D6—Captopril—systemic scleroderma	0.0573	0.0783	CbGbCtD
Loratadine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0479	0.0654	CbGbCtD
Loratadine—CYP2C19—Prednisone—systemic scleroderma	0.0475	0.0648	CbGbCtD
Loratadine—ABCB1—Prednisone—systemic scleroderma	0.0383	0.0523	CbGbCtD
Loratadine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0287	0.0392	CbGbCtD
Loratadine—CYP3A4—Prednisone—systemic scleroderma	0.0229	0.0313	CbGbCtD
Loratadine—ABCB1—Methotrexate—systemic scleroderma	0.0192	0.0262	CbGbCtD
Loratadine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000628	0.00235	CcSEcCtD
Loratadine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000628	0.00235	CcSEcCtD
Loratadine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000626	0.00234	CcSEcCtD
Loratadine—Asthenia—Mometasone—systemic scleroderma	0.000625	0.00234	CcSEcCtD
Loratadine—Hypotension—Azathioprine—systemic scleroderma	0.000624	0.00233	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000623	0.00233	CcSEcCtD
Loratadine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000623	0.00233	CcSEcCtD
Loratadine—Discomfort—Mycophenolic acid—systemic scleroderma	0.00062	0.00232	CcSEcCtD
Loratadine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000618	0.00231	CcSEcCtD
Loratadine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000616	0.0023	CcSEcCtD
Loratadine—Tachycardia—Leflunomide—systemic scleroderma	0.000615	0.0023	CcSEcCtD
Loratadine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000614	0.00229	CcSEcCtD
Loratadine—Skin disorder—Leflunomide—systemic scleroderma	0.000612	0.00229	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000608	0.00227	CcSEcCtD
Loratadine—Angioedema—Lisinopril—systemic scleroderma	0.000607	0.00227	CcSEcCtD
Loratadine—Abdominal pain—Captopril—systemic scleroderma	0.000605	0.00226	CcSEcCtD
Loratadine—Body temperature increased—Captopril—systemic scleroderma	0.000605	0.00226	CcSEcCtD
Loratadine—Nausea—Pentoxifylline—systemic scleroderma	0.0006	0.00224	CcSEcCtD
Loratadine—Malaise—Lisinopril—systemic scleroderma	0.000599	0.00224	CcSEcCtD
Loratadine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000597	0.00223	CcSEcCtD
Loratadine—Diarrhoea—Mometasone—systemic scleroderma	0.000596	0.00223	CcSEcCtD
Loratadine—Syncope—Lisinopril—systemic scleroderma	0.000595	0.00223	CcSEcCtD
Loratadine—Shock—Mycophenolic acid—systemic scleroderma	0.000592	0.00221	CcSEcCtD
Loratadine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00221	CcSEcCtD
Loratadine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00059	0.00221	CcSEcCtD
Loratadine—Hypotension—Leflunomide—systemic scleroderma	0.000589	0.0022	CcSEcCtD
Loratadine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000587	0.00219	CcSEcCtD
Loratadine—Palpitations—Lisinopril—systemic scleroderma	0.000587	0.00219	CcSEcCtD
Loratadine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000584	0.00218	CcSEcCtD
Loratadine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000584	0.00218	CcSEcCtD
Loratadine—Cough—Lisinopril—systemic scleroderma	0.000579	0.00217	CcSEcCtD
Loratadine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000576	0.00215	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000575	0.00215	CcSEcCtD
Loratadine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000571	0.00213	CcSEcCtD
Loratadine—Insomnia—Leflunomide—systemic scleroderma	0.00057	0.00213	CcSEcCtD
Loratadine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00057	0.00213	CcSEcCtD
Loratadine—Paraesthesia—Leflunomide—systemic scleroderma	0.000566	0.00212	CcSEcCtD
Loratadine—Myalgia—Lisinopril—systemic scleroderma	0.000565	0.00211	CcSEcCtD
Loratadine—Chest pain—Lisinopril—systemic scleroderma	0.000565	0.00211	CcSEcCtD
Loratadine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000565	0.00211	CcSEcCtD
Loratadine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000562	0.0021	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000561	0.0021	CcSEcCtD
Loratadine—Discomfort—Lisinopril—systemic scleroderma	0.000558	0.00209	CcSEcCtD
Loratadine—Lethargy—Methotrexate—systemic scleroderma	0.000558	0.00209	CcSEcCtD
Loratadine—Dyspepsia—Leflunomide—systemic scleroderma	0.000555	0.00207	CcSEcCtD
Loratadine—Vomiting—Mometasone—systemic scleroderma	0.000554	0.00207	CcSEcCtD
Loratadine—Dry mouth—Lisinopril—systemic scleroderma	0.000553	0.00207	CcSEcCtD
Loratadine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00055	0.00206	CcSEcCtD
Loratadine—Rash—Mometasone—systemic scleroderma	0.000549	0.00205	CcSEcCtD
Loratadine—Asthenia—Captopril—systemic scleroderma	0.000549	0.00205	CcSEcCtD
Loratadine—Dermatitis—Mometasone—systemic scleroderma	0.000549	0.00205	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000548	0.00205	CcSEcCtD
Loratadine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000546	0.00204	CcSEcCtD
Loratadine—Headache—Mometasone—systemic scleroderma	0.000546	0.00204	CcSEcCtD
Loratadine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000544	0.00203	CcSEcCtD
Loratadine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000544	0.00203	CcSEcCtD
Loratadine—Fatigue—Leflunomide—systemic scleroderma	0.000544	0.00203	CcSEcCtD
Loratadine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000542	0.00203	CcSEcCtD
Loratadine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00054	0.00202	CcSEcCtD
Loratadine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00202	CcSEcCtD
Loratadine—Constipation—Leflunomide—systemic scleroderma	0.000539	0.00202	CcSEcCtD
Loratadine—Pain—Leflunomide—systemic scleroderma	0.000539	0.00202	CcSEcCtD
Loratadine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000535	0.002	CcSEcCtD
Loratadine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000535	0.002	CcSEcCtD
Loratadine—Shock—Lisinopril—systemic scleroderma	0.000533	0.00199	CcSEcCtD
Loratadine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000532	0.00199	CcSEcCtD
Loratadine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00053	0.00198	CcSEcCtD
Loratadine—Tachycardia—Lisinopril—systemic scleroderma	0.000529	0.00198	CcSEcCtD
Loratadine—Abdominal pain—Azathioprine—systemic scleroderma	0.000528	0.00197	CcSEcCtD
Loratadine—Body temperature increased—Azathioprine—systemic scleroderma	0.000528	0.00197	CcSEcCtD
Loratadine—Skin disorder—Lisinopril—systemic scleroderma	0.000526	0.00197	CcSEcCtD
Loratadine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000525	0.00196	CcSEcCtD
Loratadine—Diarrhoea—Captopril—systemic scleroderma	0.000523	0.00196	CcSEcCtD
Loratadine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000522	0.00195	CcSEcCtD
Loratadine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00052	0.00194	CcSEcCtD
Loratadine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000519	0.00194	CcSEcCtD
Loratadine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000519	0.00194	CcSEcCtD
Loratadine—Nausea—Mometasone—systemic scleroderma	0.000517	0.00193	CcSEcCtD
Loratadine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000516	0.00193	CcSEcCtD
Loratadine—Pain—Mycophenolic acid—systemic scleroderma	0.000514	0.00192	CcSEcCtD
Loratadine—Constipation—Mycophenolic acid—systemic scleroderma	0.000514	0.00192	CcSEcCtD
Loratadine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000514	0.00192	CcSEcCtD
Loratadine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000511	0.00191	CcSEcCtD
Loratadine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000508	0.0019	CcSEcCtD
Loratadine—Hypotension—Lisinopril—systemic scleroderma	0.000506	0.00189	CcSEcCtD
Loratadine—Dizziness—Captopril—systemic scleroderma	0.000506	0.00189	CcSEcCtD
Loratadine—Depression—Prednisone—systemic scleroderma	0.000503	0.00188	CcSEcCtD
Loratadine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000502	0.00188	CcSEcCtD
Loratadine—Abdominal pain—Leflunomide—systemic scleroderma	0.000498	0.00186	CcSEcCtD
Loratadine—Body temperature increased—Leflunomide—systemic scleroderma	0.000498	0.00186	CcSEcCtD
Loratadine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000496	0.00185	CcSEcCtD
Loratadine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00185	CcSEcCtD
Loratadine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00185	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000494	0.00185	CcSEcCtD
Loratadine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000492	0.00184	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000492	0.00184	CcSEcCtD
Loratadine—Insomnia—Lisinopril—systemic scleroderma	0.00049	0.00183	CcSEcCtD
Loratadine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000489	0.00183	CcSEcCtD
Loratadine—Paraesthesia—Lisinopril—systemic scleroderma	0.000487	0.00182	CcSEcCtD
Loratadine—Vomiting—Captopril—systemic scleroderma	0.000486	0.00182	CcSEcCtD
Loratadine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00181	CcSEcCtD
Loratadine—Rash—Captopril—systemic scleroderma	0.000482	0.0018	CcSEcCtD
Loratadine—Dermatitis—Captopril—systemic scleroderma	0.000482	0.0018	CcSEcCtD
Loratadine—Somnolence—Lisinopril—systemic scleroderma	0.000482	0.0018	CcSEcCtD
Loratadine—Headache—Captopril—systemic scleroderma	0.000479	0.00179	CcSEcCtD
Loratadine—Dyspepsia—Lisinopril—systemic scleroderma	0.000477	0.00178	CcSEcCtD
Loratadine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000476	0.00178	CcSEcCtD
Loratadine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000476	0.00178	CcSEcCtD
Loratadine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000475	0.00177	CcSEcCtD
Loratadine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000468	0.00175	CcSEcCtD
Loratadine—Fatigue—Lisinopril—systemic scleroderma	0.000467	0.00175	CcSEcCtD
Loratadine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000467	0.00175	CcSEcCtD
Loratadine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00174	CcSEcCtD
Loratadine—Pain—Lisinopril—systemic scleroderma	0.000463	0.00173	CcSEcCtD
Loratadine—Constipation—Lisinopril—systemic scleroderma	0.000463	0.00173	CcSEcCtD
Loratadine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000463	0.00173	CcSEcCtD
Loratadine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000461	0.00172	CcSEcCtD
Loratadine—Diarrhoea—Azathioprine—systemic scleroderma	0.000457	0.00171	CcSEcCtD
Loratadine—Nausea—Captopril—systemic scleroderma	0.000454	0.0017	CcSEcCtD
Loratadine—Asthenia—Leflunomide—systemic scleroderma	0.000452	0.00169	CcSEcCtD
Loratadine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000447	0.00167	CcSEcCtD
Loratadine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000444	0.00166	CcSEcCtD
Loratadine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000443	0.00166	CcSEcCtD
Loratadine—Dizziness—Azathioprine—systemic scleroderma	0.000442	0.00165	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00162	CcSEcCtD
Loratadine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000432	0.00161	CcSEcCtD
Loratadine—Diarrhoea—Leflunomide—systemic scleroderma	0.000431	0.00161	CcSEcCtD
Loratadine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00161	CcSEcCtD
Loratadine—Abdominal pain—Lisinopril—systemic scleroderma	0.000428	0.0016	CcSEcCtD
Loratadine—Body temperature increased—Lisinopril—systemic scleroderma	0.000428	0.0016	CcSEcCtD
Loratadine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00159	CcSEcCtD
Loratadine—Vomiting—Azathioprine—systemic scleroderma	0.000425	0.00159	CcSEcCtD
Loratadine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000422	0.00158	CcSEcCtD
Loratadine—Drowsiness—Methotrexate—systemic scleroderma	0.000422	0.00158	CcSEcCtD
Loratadine—Rash—Azathioprine—systemic scleroderma	0.000421	0.00157	CcSEcCtD
Loratadine—Dermatitis—Azathioprine—systemic scleroderma	0.000421	0.00157	CcSEcCtD
Loratadine—Depression—Methotrexate—systemic scleroderma	0.00042	0.00157	CcSEcCtD
Loratadine—Headache—Azathioprine—systemic scleroderma	0.000418	0.00156	CcSEcCtD
Loratadine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000418	0.00156	CcSEcCtD
Loratadine—Dizziness—Leflunomide—systemic scleroderma	0.000417	0.00156	CcSEcCtD
Loratadine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000412	0.00154	CcSEcCtD
Loratadine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00153	CcSEcCtD
Loratadine—Immune system disorder—Prednisone—systemic scleroderma	0.000409	0.00153	CcSEcCtD
Loratadine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000406	0.00152	CcSEcCtD
Loratadine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000406	0.00152	CcSEcCtD
Loratadine—Arrhythmia—Prednisone—systemic scleroderma	0.000405	0.00151	CcSEcCtD
Loratadine—Vomiting—Leflunomide—systemic scleroderma	0.000401	0.0015	CcSEcCtD
Loratadine—Alopecia—Prednisone—systemic scleroderma	0.0004	0.0015	CcSEcCtD
Loratadine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000399	0.00149	CcSEcCtD
Loratadine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000398	0.00149	CcSEcCtD
Loratadine—Epistaxis—Methotrexate—systemic scleroderma	0.000398	0.00149	CcSEcCtD
Loratadine—Rash—Leflunomide—systemic scleroderma	0.000398	0.00149	CcSEcCtD
Loratadine—Dermatitis—Leflunomide—systemic scleroderma	0.000397	0.00148	CcSEcCtD
Loratadine—Nausea—Azathioprine—systemic scleroderma	0.000397	0.00148	CcSEcCtD
Loratadine—Headache—Leflunomide—systemic scleroderma	0.000395	0.00148	CcSEcCtD
Loratadine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000391	0.00146	CcSEcCtD
Loratadine—Asthenia—Lisinopril—systemic scleroderma	0.000389	0.00145	CcSEcCtD
Loratadine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00145	CcSEcCtD
Loratadine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000382	0.00143	CcSEcCtD
Loratadine—Rash—Mycophenolic acid—systemic scleroderma	0.000379	0.00142	CcSEcCtD
Loratadine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000379	0.00142	CcSEcCtD
Loratadine—Headache—Mycophenolic acid—systemic scleroderma	0.000377	0.00141	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—systemic scleroderma	0.000376	0.0014	CcSEcCtD
Loratadine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000375	0.0014	CcSEcCtD
Loratadine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000375	0.0014	CcSEcCtD
Loratadine—Nausea—Leflunomide—systemic scleroderma	0.000375	0.0014	CcSEcCtD
Loratadine—Diarrhoea—Lisinopril—systemic scleroderma	0.000371	0.00139	CcSEcCtD
Loratadine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000366	0.00137	CcSEcCtD
Loratadine—Agitation—Prednisone—systemic scleroderma	0.000362	0.00135	CcSEcCtD
Loratadine—Angioedema—Prednisone—systemic scleroderma	0.00036	0.00135	CcSEcCtD
Loratadine—Dizziness—Lisinopril—systemic scleroderma	0.000358	0.00134	CcSEcCtD
Loratadine—Nausea—Mycophenolic acid—systemic scleroderma	0.000357	0.00134	CcSEcCtD
Loratadine—Malaise—Prednisone—systemic scleroderma	0.000356	0.00133	CcSEcCtD
Loratadine—Syncope—Prednisone—systemic scleroderma	0.000354	0.00132	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—systemic scleroderma	0.000353	0.00132	CcSEcCtD
Loratadine—Loss of consciousness—Prednisone—systemic scleroderma	0.000347	0.0013	CcSEcCtD
Loratadine—Vomiting—Lisinopril—systemic scleroderma	0.000345	0.00129	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—systemic scleroderma	0.000342	0.00128	CcSEcCtD
Loratadine—Rash—Lisinopril—systemic scleroderma	0.000342	0.00128	CcSEcCtD
Loratadine—Dermatitis—Lisinopril—systemic scleroderma	0.000341	0.00128	CcSEcCtD
Loratadine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00127	CcSEcCtD
Loratadine—Hypertension—Prednisone—systemic scleroderma	0.00034	0.00127	CcSEcCtD
Loratadine—Headache—Lisinopril—systemic scleroderma	0.000339	0.00127	CcSEcCtD
Loratadine—Myalgia—Prednisone—systemic scleroderma	0.000336	0.00125	CcSEcCtD
Loratadine—Alopecia—Methotrexate—systemic scleroderma	0.000335	0.00125	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000333	0.00125	CcSEcCtD
Loratadine—Discomfort—Prednisone—systemic scleroderma	0.000332	0.00124	CcSEcCtD
Loratadine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00121	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—systemic scleroderma	0.000323	0.00121	CcSEcCtD
Loratadine—Nausea—Lisinopril—systemic scleroderma	0.000322	0.0012	CcSEcCtD
Loratadine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000322	0.0012	CcSEcCtD
Loratadine—Shock—Prednisone—systemic scleroderma	0.000317	0.00118	CcSEcCtD
Loratadine—Nervous system disorder—Prednisone—systemic scleroderma	0.000316	0.00118	CcSEcCtD
Loratadine—Tachycardia—Prednisone—systemic scleroderma	0.000314	0.00117	CcSEcCtD
Loratadine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000314	0.00117	CcSEcCtD
Loratadine—Skin disorder—Prednisone—systemic scleroderma	0.000313	0.00117	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000306	0.00114	CcSEcCtD
Loratadine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000302	0.00113	CcSEcCtD
Loratadine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00112	CcSEcCtD
Loratadine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00112	CcSEcCtD
Loratadine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00111	CcSEcCtD
Loratadine—Malaise—Methotrexate—systemic scleroderma	0.000297	0.00111	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000293	0.0011	CcSEcCtD
Loratadine—Insomnia—Prednisone—systemic scleroderma	0.000291	0.00109	CcSEcCtD
Loratadine—Paraesthesia—Prednisone—systemic scleroderma	0.000289	0.00108	CcSEcCtD
Loratadine—Cough—Methotrexate—systemic scleroderma	0.000288	0.00107	CcSEcCtD
Loratadine—Dyspepsia—Prednisone—systemic scleroderma	0.000283	0.00106	CcSEcCtD
Loratadine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00105	CcSEcCtD
Loratadine—Chest pain—Methotrexate—systemic scleroderma	0.000281	0.00105	CcSEcCtD
Loratadine—Myalgia—Methotrexate—systemic scleroderma	0.000281	0.00105	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000279	0.00104	CcSEcCtD
Loratadine—Fatigue—Prednisone—systemic scleroderma	0.000277	0.00104	CcSEcCtD
Loratadine—Discomfort—Methotrexate—systemic scleroderma	0.000277	0.00104	CcSEcCtD
Loratadine—Constipation—Prednisone—systemic scleroderma	0.000275	0.00103	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000269	0.00101	CcSEcCtD
Loratadine—Feeling abnormal—Prednisone—systemic scleroderma	0.000265	0.000991	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000264	0.000986	CcSEcCtD
Loratadine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000263	0.000984	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—systemic scleroderma	0.000261	0.000976	CcSEcCtD
Loratadine—Abdominal pain—Prednisone—systemic scleroderma	0.000254	0.000951	CcSEcCtD
Loratadine—Body temperature increased—Prednisone—systemic scleroderma	0.000254	0.000951	CcSEcCtD
Loratadine—Hypotension—Methotrexate—systemic scleroderma	0.000251	0.000939	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000245	0.000916	CcSEcCtD
Loratadine—Insomnia—Methotrexate—systemic scleroderma	0.000243	0.000909	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—systemic scleroderma	0.000241	0.000903	CcSEcCtD
Loratadine—Somnolence—Methotrexate—systemic scleroderma	0.000239	0.000894	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—systemic scleroderma	0.000237	0.000885	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000232	0.000868	CcSEcCtD
Loratadine—Fatigue—Methotrexate—systemic scleroderma	0.000232	0.000867	CcSEcCtD
Loratadine—Asthenia—Prednisone—systemic scleroderma	0.000231	0.000863	CcSEcCtD
Loratadine—Pain—Methotrexate—systemic scleroderma	0.00023	0.00086	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000222	0.000828	CcSEcCtD
Loratadine—Diarrhoea—Prednisone—systemic scleroderma	0.00022	0.000823	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00022	0.000822	CcSEcCtD
Loratadine—Dizziness—Prednisone—systemic scleroderma	0.000213	0.000795	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—systemic scleroderma	0.000213	0.000795	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—systemic scleroderma	0.000213	0.000795	CcSEcCtD
Loratadine—Vomiting—Prednisone—systemic scleroderma	0.000205	0.000765	CcSEcCtD
Loratadine—Rash—Prednisone—systemic scleroderma	0.000203	0.000758	CcSEcCtD
Loratadine—Dermatitis—Prednisone—systemic scleroderma	0.000203	0.000758	CcSEcCtD
Loratadine—Headache—Prednisone—systemic scleroderma	0.000202	0.000754	CcSEcCtD
Loratadine—Asthenia—Methotrexate—systemic scleroderma	0.000193	0.000721	CcSEcCtD
Loratadine—Nausea—Prednisone—systemic scleroderma	0.000191	0.000715	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—systemic scleroderma	0.000184	0.000688	CcSEcCtD
Loratadine—Dizziness—Methotrexate—systemic scleroderma	0.000178	0.000665	CcSEcCtD
Loratadine—Vomiting—Methotrexate—systemic scleroderma	0.000171	0.000639	CcSEcCtD
Loratadine—Rash—Methotrexate—systemic scleroderma	0.00017	0.000634	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—systemic scleroderma	0.000169	0.000633	CcSEcCtD
Loratadine—Headache—Methotrexate—systemic scleroderma	0.000168	0.00063	CcSEcCtD
Loratadine—Nausea—Methotrexate—systemic scleroderma	0.00016	0.000597	CcSEcCtD
